Iktos Partners with Galapagos utilizing AI for Drug Design
Iktos, a company specialized in Artificial Intelligence for new drug design, recently announced a collaboration with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of Galapagos drug discovery programs. Under the agreement, Iktos will apply its de […]
Iktos-Teijin Pharma Combine co-develop latest tech for new drug design
Iktos, a company specializing in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. According to the industrial sources from […]
